FIGURE 3.

A, Levels of soluble PD‐L1 (sPD‐L1) were significantly higher in patients with ENKTL [97.29 (71.67‐174.32)] or DLBCL [65.12 (49.02‐113.23)] than in healthy controls [49.97 (42.93‐56.70)]. Levels were significantly higher in ENKTL patients than in DLBCL patients. B‐F, In ENKTL patients, sPD‐L1 level varied with B, Ann Arbor stage, B, B symptoms, B, lactate dehydrogenase (LDH) concentration, B, PINK‐E scores, C, hemoglobin, D, lymphocyte count, E, lymphocyte percentage, F, copy number of Epstein‐Barr virus genome, and G, Ki‐67 index. ****P < .0001, ***P < .001, **P < .01. DLBCL, diffuse large B‐cell lymphoma; ENKTL, extranodal natural killer/T‐cell lymphoma